Skip to main
MDAI

MDAI Stock Forecast & Price Target

MDAI Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Spectral AI is a medical technology company with a focus on predictive medical diagnostics. Its DeepView System, which has been in development and clinical investigation for numerous years, uses AI algorithms to assess the healing potential of burn wounds. The recent FDA clearance for DeepView is a significant milestone and is expected to lead to early commercial adoption of the system supported by BARDA funding. With a large market potential and a license model that is expected to drive recurring revenue, Spectral AI has the potential for stable growth. The achievement of this milestone has resulted in a raised price target of $4 from $3, and the company is expected to see revenue growth of over 110% CAGR in FY26 through FY30 upon commercial launch of DeepView. However, some risks to consider include potential delays in clinical and regulatory developments, as well as competition in the market.

Bears say

Spectral AI is a promising AI company focused on the predictive medical diagnostics market, with its DeepView system offering innovative technology for assessing and treating burns and wounds. However, the company faces significant challenges in gaining regulatory clearance and commercial adoption in the highly fragmented and under-penetrated wound care market. Additionally, while the BARDA contract may provide some initial revenue, sustained profitability may be difficult to achieve without further indications or sources of non-dilutive financing for international sales.

MDAI has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Spectral AI Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Spectral AI Inc (MDAI) Forecast

Analysts have given MDAI a Strong Buy based on their latest research and market trends.

According to 1 analysts, MDAI has a Strong Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $4, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $4, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Spectral AI Inc (MDAI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.